Pharmakure was founded in 2012 by Dr. Farid Khan and Professor Andrew Doig, as a spin out from the University of Manchester’s world-leading Manchester Institute of Biotechnology. PharmaKure specialises in drug repurposing with focus on precision based therapeutics for neurodegenerative diseases.